- Home
- TLRY vs AVNS Comparison
TLRY vs AVNS Comparison
Compare TLRY & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLRY
- AVNS
- Stock Information
- Founded
- TLRY N/A
- AVNS 2014
- Country
- TLRY Canada
- AVNS United States
- Employees
- TLRY N/A
- AVNS N/A
- Industry
- TLRY Medicinal Chemicals and Botanical Products
- AVNS Industrial Specialties
- Sector
- TLRY Health Care
- AVNS Health Care
- Exchange
- TLRY Nasdaq
- AVNS Nasdaq
- Market Cap
- TLRY 871.2M
- AVNS 717.4M
- IPO Year
- TLRY 2018
- AVNS N/A
- Fundamental
- Price
- TLRY $0.95
- AVNS $15.45
- Analyst Decision
- TLRY Hold
- AVNS Hold
- Analyst Count
- TLRY 3
- AVNS 1
- Target Price
- TLRY $1.88
- AVNS N/A
- AVG Volume (30 Days)
- TLRY 51.2M
- AVNS 438.7K
- Earning Date
- TLRY 04-08-2025
- AVNS 02-26-2025
- Dividend Yield
- TLRY N/A
- AVNS N/A
- EPS Growth
- TLRY N/A
- AVNS N/A
- EPS
- TLRY N/A
- AVNS 0.34
- Revenue
- TLRY $829,216,000.00
- AVNS $681,500,000.00
- Revenue This Year
- TLRY $15.63
- AVNS $3.84
- Revenue Next Year
- TLRY $5.63
- AVNS $4.37
- P/E Ratio
- TLRY N/A
- AVNS $32.87
- Revenue Growth
- TLRY 18.38
- AVNS N/A
- 52 Week Low
- TLRY $0.83
- AVNS $14.98
- 52 Week High
- TLRY $2.97
- AVNS $25.36
- Technical
- Relative Strength Index (RSI)
- TLRY 40.67
- AVNS 36.25
- Support Level
- TLRY $0.97
- AVNS $15.16
- Resistance Level
- TLRY $1.20
- AVNS $16.75
- Average True Range (ATR)
- TLRY 0.08
- AVNS 0.52
- MACD
- TLRY -0.00
- AVNS -0.15
- Stochastic Oscillator
- TLRY 33.72
- AVNS 11.97
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
About AVNS Avanos Medical Inc.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.